The National Partner Society Abstract Achievement Awards are awarded to an international hematologist, who must be a member of the supporting organization and resident of the respective country, to help advance knowledge and inspire continued professional development in hematology. The awardees can be undergraduate students, medical students, graduate students, resident physicians, or postdoctoral MD or PhD fellows.
ASH-Haematology Society of Australia and New Zealand (HSANZ) Abstract Achievement Awards
The ASH-HSANZ AAA is granted to up to two trainees who are first or senior author and presenter of the most meritorious country-specific project.
Naranie Shanmuganathan, FRACP, FRCPA, MBBS
Royal Adelaide Hospital and SA Pathology
Abstract 49
Title: Mutated Cancer-Related Genes Detected at Diagnosis of CML and a Novel Class of Variant Associated with the Philadelphia Translocation Are Both Independent Predictors of Inferior Outcomes
632. Chronic Myeloid Leukemia: Therapy— Building the Future of CML
Saturday, December 5, 2020, 8:30 a.m. Pacific time
ASH-Japanese Society of Hematology (JSH) Abstract Achievement Awards
The ASH-JSH AAA is granted to up to three trainees who are the first or senior author and presenter of the most meritorious country specific project.
Yasunori Kogure, MD, PhD
National Cancer Center Research Institute
Abstract 280
Title: Whole-Genome Analysis of Adult T-Cell Leukemia/Lymphoma
621. Lymphoma—Genetic/Epigenetic Biology: Genetic and epigenetic profiling of malignant lymphomas
Saturday, December 5, 2020, 2:30 p.m. Pacific time
Ryunosuke Saiki, MD
Kyoto University
Abstract 385
Title: Combined Landscape of Gene Mutations and Copy Number Alterations in Clonal Hematopoiesis: Analysis in 10,612 Japanese Individuals
503. Clonal Hematopoiesis: Aging and Inflammation
Sunday, December 6, 2020, 12:45 p.m. Pacific time
Shunichiro Yasuda, MD
Tokyo Medical and Dental University
Abstract 1262
Title: MPL Overexpression Induces a High Level of Mutant-Calr/MPL Complex: A Novel Mechanism of Ruxolitinib Resistance in Myeloproliferative Neoplasms with Calr Mutations
635. Myeloproliferative Syndromes: Basic Science: Poster I
Saturday, December 5, 2020, 7:00 a.m. - 3:30 p.m. Pacific time
ASH-Society Italiana di Ematologia (SIE) Abstract Achievement Awards
The ASH-SIE AAA is granted to up to two trainees who are the first or senior author and presenter of the most meritorious country specific project.
Luca Bertamini, MD
GIMEMA
Abstract 720
Title: Poor Prognosis of Multiple Myeloma Predicted by High Levels of Circulating Plasma Cells Is Independent from Other High-Risk Features but Is Modulated By the Achievement of Minimal Residual Disease Negativity
651. Myeloma: Biology and Pathophysiology, excluding Therapy II
Monday, December 7, 2020, 1:45 p.m. Pacific time
Raffaele Palmieri, MD
University of Rome Tor Vergata
Abstract 392
Title: Validation of ELN2017 Risk Stratification in a Post-Hoc Analysis of the Prospective Biomarker-Based Gimema AML1310 Protocol
613. Acute Myeloid Leukemia: Molecular Mutations and Their Prognostic Implications
Sunday, December 6, 2020: 1:00 p.m. Pacific time
ASH-British Society of Hematology (BSH) Abstract Achievement Award
The ASH-BSH AAA is granted to up to three trainees who are the first or senior author and presenter of the most meritorious submitted abstract.
Deena Iskander, MD
Imperial College London
Abstract 2749
Title: Single-Cell Transcriptional Landscapes of Human Bone Marrow Reveal Distinct Erythroid Phenotypes Underpinned By Genotype in Diamond-Blackfan Anemia
508. Bone Marrow Failure: Poster III
Monday, December 7, 2020, 7:00 a.m. - 3:30 p.m. Pacific time
Jayna Mistry, BSc
The University of East Anglia
Abstract 451
Title: Enhanced Free Fatty Acid Uptake Via CD36 Promotes a Metabolic Switch to B-Oxidation within Hematopoietic Stem Cells in Response to Acute Infection
506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells
Sunday, December 6, 2020, 2:45 p.m. Pacific time
Rebecca Shaw, MBChB
University of Liverpool
Abstract 1773
Title: Circulating Histone Levels Correlate with the Severity of COVID-19 and the Extent of Coagulation Activation and Inflammation
321. Blood Coagulation and Fibrinolytic Factors: Poster II
Sunday, December 6, 2020, 7:00 a.m. - 3:30 p.m. Pacific time
To learn more about these new partner awards, and to apply for the future award cycle, visit www.hematology.org/awards/abstract-achievement.
